Company name change

Collaborative Medicinal Development is now Vivat Therapeutics.

We develop small-molecule ferroptosis inhibitors as disease-modifying therapies for age-related disease. The science, the team and the lead programme continue unchanged under the Vivat name.

Lead compound
VV-969
Mechanism
Ferroptosis inhibition
Initial indication
Sarcopenia